DHEA-S-7 EIA Test

Products	DHEA-S-7 EIA Test
Company	Diagnostic Systems Laboratories, Inc.
Item	DHEA-S-7 EIA Test
Features
Description	Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ester of DHEA, derived from sulfated precursors and by enzymatic conversion of DHEA in adrenal and extradrenal tissues. DHEA is the major C19 steroid secreted by the adrenal cortex, and is a precursor for testosterone and estrogen biosynthesis. DHEA possesses relatively weak androgenic activity, which for unsulfated DHEA has been estimated at ~10% that of testosterone [1]. However, the bioactivity of DHEA-S may be increased by its relatively high serum concentrations, approximately 100 to 1000-fold higher than DHEA or testosterone, and its weak affinity for its binding protein, sex-hormone binding globulin [2]. Measurement of serum DHEA-S is a useful marker of adrenal androgen synthesis. Abnormally low levels may occur in have been reported in hypoadrenalism [3], while elevated levels occur in several conditions [2,4], e.g. virilizing adrenal adenoma and carcinoma, 21-hydroxylase and 3-hydroxysteroid dehydrogenase deficiencies and in some cases of female hirsutism. As very little DHEA-S is produced by the gonads, measurement of DHEA-S levels may aid in the localization of androgen source in virilizing conditions [2,3]. Dorfman RI, Shipley RA: Androgens. John Wiley and Sons, New York, 1956, pp. 116-128. Pang S, Riddick L: Hirsutism. IN Lifshitz F (ed): Pediatric Endocrinology, A Clinical Guide, second edition. Marcel Dekker, Inc., New York, 1990, pp. 259-291. de Peretti E & Forest MG. J Clin Endocrinol Metab 47:572-577, 1978. Lee PDK. et al. Pediatrics 76:437-444, 1985.
Info	Diagnostic Systems Laboratories, Inc. Customer Service: (800) 231-7970 Web site: http://www.dslabs.com

Related medicine products :

1. DHEA-S-7 (saliva) EIA Test
2. DHEA-S-7 (saliva)
3. DHEA-S-7 RIA Test

TAG: DHEA EIA Test

...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...

Medicine Products:

Cysticercosis Antibody, IgG by ELISA Cystic Respiratory Culture Cystatin C, Serum Cyanide

(Date:12/1/2009)... Cell Therapeutics, Inc....ation at the 21st Annual Piper Jaffray Health Care...astern Time will be webcast live at www.cellthera...lace in Holmes 1 at the New York Palace Hotel, and...ntation. , , Piper Jaffray H...

(Date:12/1/2009)...l magnetic resonance imaging (fMRI) to evaluate br... to lead as children incur permanent brain injury....eting of the Radiological Society of North America... of the brain is spared from lead exposure," said ... scientist at Cincinnati Children,s Hospital Medic...

(Date:11/30/2009)...st Fertility is attempting to dispel the notion th...nd send patients home pregnant with multiples. Wh...nt, their priority is health and safety. In addit...s can put on a country’s healthcare system. ... 2009 -- Many patients and doctors in the U.K. wor...

(Date:11/30/2009)...swire/ -- Low-dose radiation from annual mammograp...men with genetic or familial predisposition to bre...t the annual meeting of the Radiological Society o...risk for breast cancer, screening is very importan...sidering mammography for screening young women, pa...

(Date:11/30/2009)... 30 In Massachusetts, a... are cared for at home, so the Alzheimer,s Associa... Helpline during the holiday season. For most fami...ogetherness and sharing, but for a family dealing ...nd filled with special challenges, according to th...

Breaking Medicine News(10 mins):Health News:Childhood lead exposure causes permanent brain damage 2 Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2 Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3 Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 2 Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 3 Health News:Alzheimer's Caregivers Face Holiday Stress 2

[0] Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast [0] Childhood lead exposure causes permanent brain damage [0] East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program [1] Mammography May Increase Breast Cancer Risk in Some High-Risk Women [0] Alzheimer's Caregivers Face Holiday Stress

...,(NYSE: PRE ) announced that its Board of Directo... 1, 2007 - February 29, 2008 of $0.421875 per shar...mable Preferred Shares, and,$0.40625 per share on ...ary 22, 2008., PartnerRe Ltd. is a leading global...

...oth conventional gasoline and stored electricity c...le technology is developed, according to researche...ion International Journal of Automotive Technology...acques Chanaron Research Director within the Frenc...

...nds-on Learning, NEW YORK, Feb. 7 Immediate acce...quality medical care and can mean the,difference b... Health,Record (EHR) systems, used by physicians, ...w textbook,Hamilton/Electronic Health Records, to ...

....,(Nasdaq: ATRC ), a medical device company and a...ounced today the appointment of Mark A. Collar to ...tly retired from a,distinguished career with The P...Mark to the Board of Directors of AtriCure,",said ...

... say , , THURSDAY, Feb. 7 (HealthDay News)...isdom on its head, researchers report that babies ... health problems than babies born to men over 40. ... and neonatal deaths," said Dr. Shi Wu Wen, an ass...

...nced financial,and operating results for the fourt...th Quarter Summary:, -- Revenues increased 6...totaled $278 million, compared to $122 million in ...r doubtful accounts increased to $912 million, fro...

PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares The trouble with hybrids McGraw-Hill Higher Education Publishes Text on Innovative Electronic Health Records System AtriCure Appoints Mark A. Collar to its Board of Directors Birth Problems Linked to Teenage Fathers HCA Reports Fourth Quarter - Year End 2007 Results

(Date:11/30/2009)...OVINA, Calif., Nov. 30 StemCyte, I...zation agreement with Academia Sinica, the Nationa...thods and Intellectual Property (IP) related to th...is method and IP was pioneered by a team led by Pr...Sinica. Professor Lin is currently the exclusive ...

(Date:11/30/2009)...NG OF PRUSSIA, Pa., Nov. 30 Cytoki...tion of a Phase I study of CPSI-2364, its orally a...of TNF-alpha and other pro-inflammatory cytokines....lation study in healthy volunteers confirm the saf... ,, All 30 enrolled subjects completed the stu...

(Date:11/30/2009)..., WALTHAM, Mass., Nov. 30 Accordi...authority on medical technology market intelligenc...e market declined by almost 5% over 2008 as patien...of the economic crisis. The market will, however, ...o the strong pre-recession growth rates of over 15...

Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2 StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3 Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2 Facial Injectables Emerge From the Recession 2 Facial Injectables Emerge From the Recession 3 Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 1 Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 2 Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 3 Kids With Eye Condition at Risk for Poor Mental Health 48767 1 Kids With Eye Condition at Risk for Poor Mental Health 48767 2 Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 1 Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 2

[0] StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke [0] Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 [0] Facial Injectables Emerge From the Recession